Company Info
Year Established2013
Ticker
AMLX
Exchange
NASDAQ
Contacts
Josh CohenCo-Founder & Co-CEO
James M. Frates
CFO
Justin Klee
Co-Founder & Co-CEO
Gina M. Mazzariello
CLO
Tom Holmes
CTO
Company Description
Amylyx Pharmaceuticals is a biopharmaceutical company best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.